After SARS-CoV-2 began to rapidly spread across the globe in 2020, there was a rush to develop safe and effective vaccines that could slow the spread and limit the severity of the virus. Although the mRNA vaccines reduce symptoms of COVID-19 by more than 90%, the efficacy of these mRNA vaccines in immunocompromised people has […]
